Trial Profile
A Phase 1, Double-Blind, Randomised, Placebo-Controlled, Study to Evaluate the Safety and Pharmacokinetics of GBR 900 in Adult Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Feb 2017
Price :
$35
*
At a glance
- Drugs GBR 900 (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Glenmark Pharmaceuticals Ltd
- 23 Jan 2017 Status changed from active, no longer recruiting to completed.
- 17 Jun 2016 Planned End Date changed from 1 Mar 2016 to 1 Mar 2017.
- 17 Jun 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2017.